KIMBERLY LABOSKI: Open Payments
NPI 1750025995 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 15 payments from 9 companies in 2025. Trend: 2023 $434 · 2024 $256 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $142 |
| Phathom Pharmaceuticals, Inc. | 1 | $93 |
| Novo Nordisk Inc | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| Celltrion USA Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: VELSIPITY, VOQUEZNA, Wegovy, RINVOQ, VEGZELMA, SIMLANDI, TRELEGY ELLIPTA, XIFAXAN.
Industry payments across PA — which companies pay providers there.
